Henan Lingrui Pharmaceutical Co., Ltd. (SHA: 600285)

Henan Lingrui Pharmaceutical Revenue

Henan Lingrui Pharmaceutical had revenue of 853.11M CNY in the quarter ending September 30, 2024, with 5.83% growth. This brings the company's revenue in the last twelve months to 3.56B, up 10.28% year-over-year. In the year 2023, Henan Lingrui Pharmaceutical had annual revenue of 3.31B with 10.31% growth.

• Revenue (ttm): 3.56B
• Revenue Growth: +10.28%
• P/S Ratio: 3.35
• Revenue / Employee: 1.41M
• Employees: 2,530
• Market Cap: 12.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.31B	309.61M	10.31%
Dec 31, 2022	3.00B	308.35M	11.45%
Dec 31, 2021	2.69B	361.93M	15.52%
Dec 31, 2020	2.33B	174.53M	8.09%
Dec 31, 2019	2.16B	103.94M	5.06%